ORCL ORACLE CORP
Price Chart
Executive Summary
Wedbush initiated coverage on Oracle (ORCL) with an Outperform rating and $225 price target, implying 27.6% upside from the current $176.28. The firm’s 57% accuracy rate (917/1604 calls) is above average but below top-tier peers. Consensus is strongly bullish: 66.7% Buy-rated (40 of 60 analysts), with a mean PT of $243.71. Recent analyst momentum shows 1 upgrade and 0 downgrades in the past 30 days. EPS estimates are trending upward, with 3 revisions higher in the last 30 days for +1y EPS. Institutional activity is mixed: Norges Bank and Two Sigma initiated large new positions, while Causeway and Mawer fully exited. Insider selling totaled $2.64M on April 16. Congressional trades show minor buys and sells. Earnings due June 9 — within 45 days — add timing relevance. Wedbush’s call aligns with bullish consensus but is below the median PT of $220.
Impact Score
Consensus & Targets
Of 60 total analysts, 40 rate ORCL a Buy (66.7%), 10 Hold (16.7%), and 1 Sell (1.7%). The consensus direction is strongly bullish, with no recent downgrades. This initiation aligns with the prevailing bullish sentiment.
The consensus mean price target is $243.71, median $220, high $400, low $155. ORCL trades at $176.28, implying 38.4% upside to the mean and 24.8% to the median. Wedbush’s $225 PT is 7.3% above the median and 7.4% below the mean, placing it in the upper tier of targets but not extreme.
Recent Analyst Activity
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-04-24 | Wedbush | initiate | Outperform | $225.00 |
| 2026-04-23 | Morgan Stanley | maintain | Equal-Weight | $207.00 |
| 2026-04-07 | Stephens & Co. | reiterate | Equal-Weight | $254.00 |
| 2026-03-16 | Mizuho | maintain | Outperform | $320.00 |
| 2026-03-13 | Guggenheim | reiterate | Buy | $400.00 |
| 2026-03-12 | Citigroup | maintain | Buy | $320.00 |
| 2026-03-11 | Stifel | maintain | Buy | $220.00 |
| 2026-03-11 | Barclays | maintain | Overweight | $240.00 |
| 2026-03-11 | BMO Capital | maintain | Outperform | $200.00 |
| 2026-03-11 | TD Cowen | reiterate | Buy | $250.00 |
In the past 30 days, ORCL saw 1 upgrade and 0 downgrades. EPS estimates are rising: +1y EPS revised up 3 times and down once in the past 30 days, current estimate $7.98, up from $7.97. Near-term estimates show minor downward drift in 0q EPS, but full-year 0y EPS also revised up twice, down zero.
Firm Track Record — Wedbush
Wedbush accuracy: 57% on 1604 calls | avg return: 7.2%
Industry benchmark: mean 51% ± 11%. Top tier: ≥61% (mean + 1σ). Based on 15 firms with ≥5 scored calls.
| Firm | Accuracy | Calls | Avg Return | vs Average |
|---|---|---|---|---|
| Oppenheimer | 100% | 2/2 | 16.8% | top tier |
| WestPark Capital | 100% | 2/2 | 50.7% | top tier |
| Keybanc | 71% | 5/7 | 11.9% | top tier |
| Deutsche Bank | 67% | 2/3 | 13% | top tier |
| Morgan Stanley | 67% | 6/9 | 14.9% | top tier |
| UBS | 64% | 7/11 | 5.6% | top tier |
| Guggenheim | 64% | 7/11 | 12.2% | top tier |
| Jefferies | 63% | 5/8 | 9.5% | top tier |
| B of A Securities | 63% | 5/8 | 6.8% | top tier |
| Stifel | 63% | 5/8 | 7.7% | top tier |
Wedbush has a 57% accuracy rate (917 correct out of 1,604 rated calls) with an average return of 7.2%, placing it above average but below top-tier firms. Oppenheimer (100%, 2/2), WestPark (100%, 2/2), and Keybanc (71%, 5/7) lead in accuracy. Morgan Stanley (67%, 6/9) and Mizuho (57%, 4/7) are peers with stronger returns.
Earnings Estimates
Next earnings: Jun 9, 2026
| Period | EPS Est. | EPS Range | Revenue | Revisions (7d) |
|---|---|---|---|---|
| +1q | $1.68 | $1.51 — $1.84 | $19.0B | ↑1 ↓0 |
| 0y | $7.46 | $6.59 — $7.69 | $67.2B | ↑1 ↓0 |
| +1y | $7.98 | $6.16 — $9.26 | $88.3B | ↑1 ↓0 |
| 0q | $1.96 | $1.76 — $2.03 | $19.1B | ↑0 ↓0 |
Cross-Platform Signals
Institutional activity is divergent: Norges Bank ($4.34B new) and Two Sigma ($151.7M, +1369.6%) initiated or expanded positions, while Causeway and Mawer exited entirely. Renaissance Technologies started a new $323K stake. Insider activity shows one sell: Stuart Levey sold $2.64M on April 16. Congressional trades show two buys and one sell, all in minimal ranges. Short interest is elevated at 13.4M shares, but short ratio of 60.4% reflects high off-exchange volume rather than pure bearishness.
Actionable Insight
Wedbush’s initiation is a mildly bullish signal from a moderately accurate firm, aligning with strong consensus but not offering contrarian edge. Watch for institutional follow-through ahead of June 9 earnings; long exposure is justified but not urgent.
Documents Analyzed
Report based on filing metadata.
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 1, 2026
20d ago
|
ANALYST-UPGRADE
| $162.75 $152.82 | ▼ −6.10% | ▼ −3.91% | $191.68 (+17.78%) |
|
Apr 24, 2026
27d ago
|
ANALYST-UPGRADE
| $173.27 $161.39 | ▼ −6.85% | ▼ −7.76% | $191.68 (+10.62%) |
|
Mar 30, 2026
7w ago
|
Court Ruling
| $138.79 $142.81 | ▲ +2.90% | ▼ −1.40% | $191.68 (+38.11%) |
|
Feb 28, 2026
11w ago
|
Institutional Cluster
| $149.18 $151.54 | ▲ +1.58% | ▲ +2.79% | $191.68 (+28.49%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access